オプションチェーンは、CV Sciencesの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、CV Sciencesの市場センチメントを評価します。.

CV Sciences (OTC:CVSI) 株価情報, オプションチェーン

CV Sciences

CV Sciences Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol. The Company sells its products under tradenames, such as +PlusCBD and PlusCBD Pet. The Company's products are sold in a variety of market sectors including nutraceutical, beauty care, and specialty foods. The company's hemp-based products are predominantly sold in North America and primarily in the retail space. The company generates revenue from Retail Sales and E-Commerce sales of its product.

CV Sciences Inc

News

VXRT

Vaxart Entered Into Modification Increasing Project Funding To $460.7M, With Trial Allotment Rising By $37.7M To $134.2M For Clinical Site Readiness And mRNA Comparator Distribution

Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) has outperformed the market over the past 10 years by 10.73% on an annualized basis producing an average annual return of 22.07%. Currently, Apollo Global Management has a market capitalization of $98.65 billion. 
Buying $1000 In APO: If an investor had bought $1000 of APO stock 10 years ago, it would be worth $7,345.31 today based on a price of $174.35 for APO at the time of writing.
<h3>Apollo Global Management's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735309809_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In Apollo Global Management 10 Years Ago Would Be Worth This Much Today

Legal

NTRB

Nutriband Extends Chinese Patent To Macao Titled "Abuse and Misuse Deterrent Transdermal Systems"

<ul>
<li>TSLA</li>
<li>KULR</li>
<li>LUNR</li>
<li>NVDA</li>
<li>QS</li>
<li>RGTI</li>
<li>RKLB</li>
<li>AAPL</li>
<li>AMD</li>
<li>ACHR</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

ACHR

KULR

LUNR

NVDA

RGTI

RKLB

TSLA

Top 10 Trending Stocks On WallStreetBets As Of December 27, 2024 (Via Swaggy Stocks)

Following considerable financial support <a href="https://www.benzinga.com/24/12/42382407/ripple-ceo-brad-garlinhouse-admits-204m-crypto-super-political-action-committee-wouldnt-exist-if-gary-gensler-hadnt-been-the-sec-chair">during the 2024 election</a>, the digital asset industry is positioning itself for a significant transformation in how it is regulated.
What Happened: After years of dealing with unclear federal policies, and some hostile action by regulators, a change could be on the horizon under a new presidential administration, <a href="https://thehill.com/business/5054066-crypto-industry-2024-election-legislation/">according</a> to The Hill.
President-elect Donald Trump, who had earlier criticized digital currencies, shifted his stance during his campaign, to become the first presidential candidate to <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38952866/trump-accepts-cryptocurrency-donations-in-bitcoin-ethereum-shiba-inu-dogecoin-and-more-say">receive donations in digital assets</a>.
This shift, coupled with bipartisan support within Congress, creates an opening for the passage of important legislation impacting the cryptocurrency sector.
According to Kristin Smith, head of the Blockchain Association, the combination of a <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41654131/pro-crypto-congress-in-2025-experts-see-stablecoins-as-key-area-for-advancement">crypto-friendly Congress</a> and president makes it possible to finally get supportive regulatory policy implemented, including measures about stablecoins and market structures.
Smith also stressed the need for unity within the industry, in order to properly articulate its needs to Washington D.C.
The <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/39004550/exclusive-all-you-need-to-know-about-the-fit21-crypto-bill">FIT21 Act</a> is a key piece of legislation, intended to clarify the respective roles of the SEC and CFTC, to create needed regulatory boundaries.
The legislation was successful in the House last year, but failed in the Senate, therefore the crypto sector will aim to have it reintroduced. 
Rep. French Hill (R-AR), incoming Chair of the House Financial Services Committee, has listed this type of regulatory policy as one of his top priorities.
The SEC&#8217;s approach under Gary Gensler, was perceived by many in the industry as being overly harsh, and focused on enforcement actions, rather than clear guidance.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42699697/bitcoin-ethereum-etfs-break-4-day-outflow-streak-net-592-inflows-on-thursday">Bitcoin, Ethereum ETFs Break 4-Day Outflow Streak, Net $592 Inflows On Thursday</a>
Why It Matters: The new Trump administration is expected to be more accommodating.
Former SEC Commissioner Paul Atkins, known for his <a href="https://www.benzinga.com/24/12/42300549/paul-atkins-reportedly-tapped-for-sec-chair-under-trump-administration">support of crypto</a>, has already been nominated to replace Gensler.
Trump&#8217;s announcement of a new &#8220;<a href="https://www.benzinga.com/24/12/42356067/venture-capitalist-david-sacks-appointed-as-white-house-ai-crypto-czar-by-trump">crypto council</a>&#8221; led by David Sacks is another indication of a more friendly administration toward crypto.
The future leadership of the CFTC remains in question, but with a number of well regarded crypto advocates being mentioned as candidates.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42690488/are-donald-trumps-ambitious-bitcoin-goals-feasible">Are Donald Trump&#8217;s Ambitious Bitcoin Goals Feasible?</a></li>
</ul>
Image: Flickr

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Crypto Industry Anticipates Policy Overhaul Under Trump Administration

Streaming giant Netflix Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) ratings for its <a href="https://www.benzinga.com//node/42695495">NFL debut on Christmas Day</a> lagged expectations compared to traditional broadcast and cable TV offerings, CNN <a href="https://edition.cnn.com/2024/12/26/media/netflix-nfl-ratings/index.html" target="_blank" rel="noreferrer noopener">reports</a>. The stock is trading lower on Friday.
Netflix made history by <a target="_blank" href="https://www.benzinga.com/24/12/42689806/netflix-to-release-beyonce-bowl-nfl-halftime-performance-as-standalone-special" rel="noreferrer noopener">streaming two live</a> NFL games on Christmas Day.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42675098/netflix-takes-vmware-to-court-over-patent-infringement-claims" rel="noreferrer noopener">Broadcom and Netflix Clash Over Patent Disputes Ahead of 2025 Trial</a>
The exclusive matchups, part of a three-year agreement valued at $150 million annually, included the Kansas City Chiefs facing the Pittsburgh Steelers and the Baltimore Ravens taking on the Houston Texans.
Beyoncé delivered a <a target="_blank" href="https://about.netflix.com/en/news/beyonce-delivers-epic-gift-of-a-halftime-performance-beyonce-bowl-is-coming" rel="noreferrer noopener">12-minute halftime show</a> in her hometown during the Ravens-Texans game in Houston. Dubbed the &#8220;Beyoncé Bowl&#8221; by Netflix, the performance included the first live renditions of tracks from her &#8220;Cowboy Carter&#8221; album. Beyoncé inked a $60 million&nbsp;deal&nbsp;with Netflix in 2019. Beyoncé&#8217;s set also featured guest appearances from Shaboozey, Post Malone, and her daughter, Blue Ivy Carter.
The Ravens-Texans game, airing late in the day, attracted 24.3 million viewers, while the earlier Chiefs-Steelers matchup garnered 24.1 million, CNN cites Nielsen data. Although these games became the most-streamed in NFL history, traditional TV Christmas broadcasts in 2023 outperformed them. The Raiders-Chiefs game on CBS drew 29.2 million viewers, the Eagles-Giants clash on Fox reached 29 million, and ESPN&#8217;s airing of the 49ers-Ravens matchup pulled in 27.1 million viewers, CNN cites Nielsen.
&#8220;Beyoncé Bowl&#8221; peaked viewership to over 27 million during the Ravens-Texans game, CNN cites Nielsen.
The NBA saw significant success this Christmas, with its five-game lineup achieving an 84% viewership increase compared to last year. Meanwhile, Nielsen and Netflix reported that 65 million people watched at least one minute of Netflix&#8217;s NFL broadcast, the Hollywood Reporter <a href="https://www.hollywoodreporter.com/tv/tv-news/netflix-nfl-christmas-tv-ratings-1236094025/" target="_blank" rel="noreferrer noopener">reports</a>. 
Netflix plans to release its global viewership data on the games next week, allowing for a more precise comparison to its last major sporting event, November&#8217;s Jake Paul-Mike Tyson boxing match.
The previous record for a streaming-only NFL game was set by Comcast Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) Peacock&#8217;s January wild card playoff, which drew 23 million viewers. Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Prime Video averages 13.34 million viewers for its Thursday Night Football broadcasts, a 12% increase from last year. In comparison, Peacock attracted 14 million viewers during the season&#8217;s opening week.
Netflix&nbsp;stock surged over 97% year-to-date.
Oppenheimer&#8217;s Jason Helfstein flagged Netflix as the sole investable <a target="_blank" href="https://www.benzinga.com/general/sports/24/12/42512587/netflix-analyst-say-its-only-investable-media-stock-projects-150-million-nfl-christmas-day-boost" rel="noreferrer noopener">mainstream media stock</a> backed by ad revenue potential from NFL Christmas Day games and live events as it successfully kills its competitors.
Jim Cramer&nbsp;of CNBC voiced firm <a target="_blank" href="https://www.benzinga.com/markets/equities/24/12/42452602/jim-cramer-bullish-in-netflix-as-stock-nears-1000-amid-streaming-success" rel="noreferrer noopener">buying conviction for</a>&nbsp;the company.
Investors can gain exposure to Netflix through The Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) and Vanguard Growth ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VUG#NYSE">VUG</a>).
Price Actions:&nbsp;NFLX stock is down 0.67% at $917.95 premarket at last check Friday.&nbsp;
Also Read:
<ul>
<li><a href="https://www.benzinga.com/media/24/12/42554393/disneys-marvel-rivals-game-hits-20-million-players-proves-superhero-power-still-reigns" target="_blank" rel="noreferrer noopener">Disney&#8217;s Marvel Rivals Game Hits 20 Million Players, Proves Superhero Power Still Reigns</a></li>
</ul>
Photo courtesy of Netflix.

Tech

Media

AMZN

CMCSA

NFLX

Netflix's NFL Debut Brings Record Streams But Lags Traditional TV: Report

In the current session, Teleflex Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFX#NYSE">TFX</a>) is trading at $180.00, after a 0.08% decrease. Over the past month, the stock decreased by 6.59%, and in the past year, by 28.07%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2024/1735308911_0.png" alt="Past Year Chart" />

<h3>How Does Teleflex P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 67.67 in the Health Care Equipment &amp; Supplies industry, Teleflex Inc. has a lower P/E ratio of 35.74. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1735308911_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

P/E Ratio Insights for Teleflex

Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) has outperformed the market over the past 15 years by 5.26% on an annualized basis producing an average annual return of 17.03%. Currently, Eaton Corp has a market capitalization of $135.42 billion. 
Buying $1000 In ETN: If an investor had bought $1000 of ETN stock 15 years ago, it would be worth $10,577.11 today based on a price of $340.16 for ETN at the time of writing.
<h3>Eaton Corp's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735308908_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Eaton Corp 15 Years Ago Would Be Worth Today

Crypto
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42700088/dogecoin-jumps-19-in-christmas-week-rally-what-is-going-on">Dogecoin Jumps 19% In Christmas Week Rally: What Is Going On?</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42699697/bitcoin-ethereum-etfs-break-4-day-outflow-streak-net-592-inflows-on-thursday">Bitcoin, Ethereum ETFs Break 4-Day Outflow Streak, Net $592 Inflows On Thursday</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42698826/bitcoin-options-worth-over-14-billion-expired-today-one-of-the-biggest-events-in-history-heres-what-crypto-investors-should-expect">Bitcoin Options Worth Over $14 Billion Expired Today, One Of The Biggest Events In History: Here&#8217;s What Crypto Investors Should Expect</a></li>
<li><a href="https://www.benzinga.com/24/12/42697066/vivek-ramaswamys-strive-applies-for-bitcoin-bond-etf-that-will-track-microstrategys-convertible-securities-market">Vivek Ramaswamy&#8217;s Strive Applies For &#8216;Bitcoin Bond&#8217; ETF That Tracks MicroStrategy&#8217;s Convertible Securities Market</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42696957/all-vitalik-buterin-wanted-for-xmas-was-a-hippopotamus-ethereum-co-founder-is-now-the-adoptive-father-of-viral-sensation-moo-deng">All Vitalik Buterin Wanted For Xmas Was A Hippopotamus — Ethereum Co-Founder Is Now The Adoptive Father Of Viral Sensation Moo Deng</a></li>
</ul>
US Markets­­­­­­­­
<ul>
<li><a href="https://www.benzinga.com/24/12/42700098/us-markets-likely-headed-for-10-correction-says-jay-woods-trumps-tariff-plans-musk-co-led-doge-could-be-partially-to-blame">US Stocks Likely Headed For 10% Correction, Says Top Strategist, Points Out &#8216;Horrible Market Breadth:&#8217; Trump&#8217;s Tariff Plans, Musk Co-Led DOGE Could Be Partially To Blame For Decline</a></li>
<li><a href="https://www.benzinga.com/markets/futures/24/12/42699993/us-stocks-to-open-lower-as-index-future-decline-analysts-remain-upbeat-about-santa-rally">US Stocks To Open Lower As Index Future Decline: Analysts Remain Upbeat About Santa Rally</a></li>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42698415/expert-warns-of-potential-grinch-pinch-impacting-santa-claus-rally-the-outlook-for-stocks-can-be-quite-negative">Expert Warns Of Potential &#8216;Grinch Pinch&#8217; Impacting Santa Claus Rally: &#8216;The Outlook For Stocks Can Be Quite Negative&#8217;</a></li>
<li><a href="https://www.benzinga.com/24/12/42697989/dow-edges-higher-in-thin-holiday-trading-fear-declines-among-us-investors-but-fear-greed-index-remains-in-fear-zone">Dow Edges Higher In Thin Holiday Trading As Tesla, Apple Surge: Investor Sentiment Improves, But Greed Index Remains In &#8216;Fear&#8217; Zone</a></li>
</ul>
US Politics
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42699729/ark-invests-cathie-wood-urges-trumps-incoming-administration-to-implement-retroactive-tax-cuts-for-economic-boost-from-january-1">Ark Invest&#8217;s Cathie Wood Urges Trump&#8217;s Incoming Administration To Implement Retroactive Tax Cuts For Economic Boost From January 1</a></li>
</ul>
World Economy
<ul>
<li><a href="https://www.benzinga.com/24/12/42699386/europe-markets-advance-asia-mixed-oil-prices-rise-on-china-recovery-hopes-gold-dips-global-markets-today-while-us-slept">Europe And Asia Markets Gain; Dollar Set For 7% Annual Gain &#8211; Global Markets Today While Us Slept</a></li>
</ul>
Tech
<ul>
<li><a href="https://www.benzinga.com/24/12/42699969/taiwan-semiconductor-expands-in-taiwan-five-new-factories-aim-to-strengthen-chipmaking-industry">Taiwan Semiconductor Expands Domestically With 5 New Factories</a></li>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42699730/steve-jobs-knew-what-macbook-should-be-like-in-1983-it-took-apple-25-years-to-bring-his-vision-to-life-with-aapl-stock-at-record-highs-heres-what-analysts-say">Steve Jobs Knew What MacBook Should Be Like In 1983 — It Took Apple 25 Years To Bring His Vision To Life: With AAPL Stock At Record Highs, Here&#8217;s What Analysts Say</a></li>
<li><a href="https://www.benzinga.com/24/12/42699617/top-3-tech-and-telecom-stocks-that-may-rocket-higher-in-q4">Top 3 Tech And Telecom Stocks That May Rocket Higher In Q4</a></li>
<li><a href="https://www.benzinga.com/markets/24/12/42699339/gamestop-shares-dip-in-fridays-premarket-after-surging-nearly-6-in-last-session-fueled-by-roaring-kittys-christmas-present">GameStop Shares Dip In Friday&#8217;s Premarket After Surging Nearly 6% In Last Session, Fueled By Roaring Kitty&#8217;s &#8216;Christmas Present</a></li>
<li><a href="https://www.benzinga.com/markets/24/12/42698903/larry-ellisons-wealth-soars-by-75b-trailing-only-elon-musk-and-jeff-bezos-as-oracle-posts-its-biggest-stock-rally-since-the-dot-com-era">Larry Ellison&#8217;s Wealth Soars By $75B, Trailing Only Elon Musk And Jeff Bezos, As Oracle Posts Its Biggest Stock Rally Since The Dot-Com Era</a></li>
<li><a href="https://www.benzinga.com/24/12/42698198/quantum-computing-stock-qubt-has-more-than-doubled-while-bitcoin-has-dropped-since-googles-willow-reveal-what-does-this-mean">Quantum Computing Stock QUBT Has More Than Doubled While Bitcoin Has Dropped Since Google&#8217;s &#8216;Willow&#8217; Reveal: What Does This Mean?</a></li>
<li><a href="https://www.benzinga.com/tech/24/12/42697954/key-nvidia-supplier-warns-ai-spending-slowdown-may-trigger-vicious-downturn-for-chipmakers">Key Nvidia Supplier Warns AI Spending Slowdown May Trigger &#8216;Vicious&#8217; Downturn For Chipmakers</a></li>
<li><a href="https://www.benzinga.com/general/market-summary/24/12/42697827/zeta-global-shares-rise-over-126-in-2024-beating-its-peers-should-you-buy-sell-or-hold-heres-more">Zeta Global Shares Beat Peers To Rise 125% In 2024: Breaking Down The Numbers</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42696805/palantir-touted-as-next-oracle-by-dan-ives-here-is-why-the-wedbush-analyst-called-the-company-a-table-pounder">Palantir Touted As &#8216;Next Oracle&#8217; By Dan Ives: Here Is Why The Wedbush Analyst Called The Company A &#8216;Table Pounder&#8217;</a></li>
</ul>
Electric Vehicle
<ul>
<li><a href="https://www.benzinga.com/tech/24/12/42700153/teslas-lawsuit-has-startup-evject-looking-at-a-potential-partnership-with-volkswagen">Tesla&#8217;s Lawsuit Has Startup EVject Looking At A Potential Partnership With Volkswagen</a></li>
<li><a href="https://www.benzinga.com/24/12/42697605/byd-offers-discounts-of-up-to-115-on-select-evs-as-year-end-nears">BYD Offers Discounts Of Up To 11.5% On Select EVs As Year End Nears</a></li>
<li><a href="https://www.benzinga.com/news/global/24/12/42697306/onvo-sells-20000-evs-in-100-days-of-launch-gearing-to-be-nios-best-selling-brand">Onvo Sells 20,000 EVs In 100 Days Of Launch, Gearing To Be Nio&#8217;s Best-Selling Brand</a></li>
</ul>
Consumer
<ul>
<li><a href="https://www.benzinga.com/24/12/42698032/unifirst-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">UniFirst Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
Industrial
<ul>
<li><a href="https://www.benzinga.com/24/12/42699776/top-2-industrials-stocks-that-may-crash-this-month">Top 2 Industrials Stocks That May Crash This Month</a></li>
<li><a href="https://www.benzinga.com/tech/24/12/42699274/boeing-engineers-leave-struggling-planemaker-for-space-companies-report">Boeing Engineers Leave Struggling Planemaker For Space Companies: Report</a></li>
</ul>
Healthcare
<ul>
<li><a href="https://www.benzinga.com/24/12/42700253/takedas-hyqvia-approved-in-japan-to-treat-immunodeficiency">Takeda&#8217;s HYQVIA Approved in Japan To Treat Immunodeficiency</a></li>
<li><a href="https://www.benzinga.com/24/12/42698570/why-evaxion-biotech-shares-are-trading-higher-by-around-62-here-are-20-stocks-moving-premarket">Why Evaxion Biotech Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket</a></li>
</ul>
General
<ul>
<li><a href="https://www.benzinga.com/24/12/42698881/elon-musk-applauds-contribution-of-german-scientist-wernher-von-braun-to-americas-space-program">Elon Musk Applauds Contribution Of German Scientist Wernher Von Braun To America&#8217;s Space Program</a></li>
</ul>
Image via Shutterstock

$BTC

$ETH

Dogecoin Surges 19% in Christmas Week Rally; GameStop Drops Premarket After 6% Surge on Roaring Kitty's Boost; Boeing Engineers Depart for Space Industry Amid Challenges: Report - Top Headlines Today While US Slept

WIIM

CBAT

CBAK Energy Technology shares are trading higher after the company announced it secured orders from Anker Innovations.

Offerings

ATNF

180 Life Sciences Corp. Enters Securities Purchase Agreement With Institutional Investors To Sell 1.2M Shares In Registered Direct Offering; Also Agreed To Issue Unregistered Warrants To Purchase Up To 1.2M Shares, Gross Proceeds Expected To Be $2.9M

Arthur J. Gallagher & Co. Acquires BMR Insurance; Terms Not Disclosed

CBAK Energy Technology Secures Orders From Anker Innovations; Secures Order For 2024 Approx. $30M-$35M

Jefferies Financial Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>) will release earnings results for its fourth quarter, after the closing bell on <a href="https://www.benzinga.com/quote/jef/earnings">Wednesday, Jan. 8, 2025</a>.
Analysts expect the New York-based company to report quarterly earnings at 91 cents per share, up from 30 cents per share in the year-ago period. Jefferies Financial projects to report revenue of $1.77 billion for the recent quarter, compared to $1.2 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Sept. 25, Jefferies Financial reported quarterly sales of $1.68 billion, which missed the analyst consensus estimate of $1.71 billion.
Jefferies Financial shares gained 1.5% to close at $79.80 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/JEF/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Morgan Stanley analyst Ryan Kenny upgraded the stock from Equal-Weight to Overweight and raised the price target from $67 to $97 on Dec. 9. This analyst has an accuracy rate of 62%.</li>
<li>Oppenheimer analyst Chris Kotowski maintained an Outperform rating and raised the price target from $73 to $83 on Nov. 14. This analyst has an accuracy rate of 85%.</li>
<li>UBS analyst Brennan Hawken initiated coverage on the stock with a Buy rating and a price target of $67 on Sept. 17. This analyst has an accuracy rate of 71%.</li>
</ul>
Considering buying JEF stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="623" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27041548/image-212-1024x623.png" alt="" class="wp-image-708768" style="width:585px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27041548/image-212-1024x623.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27041548/image-212-300x182.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27041548/image-212-768x467.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27041548/image-212.png 1090w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42684254/top-3-utilities-stocks-youll-regret-missing-in-december">Top 3 Utilities Stocks You&#8217;ll Regret Missing In December</a></li>
</ul>

Earnings

Price Target

Jefferies Financial Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Castellum Prices 4,355,000 Share Offering At $0.85/Share

Financing

PGEN

Precigen Enters Private Placement Agreement For Sale Of Convertible Preferred Stock For Gross Proceeds Of $79M

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Goldman Sachs cut the price target for Bright Horizons Family Solutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFAM#NYSE">BFAM</a>) from $162 to $142. Goldman Sachs analyst George Tong maintained a Buy rating. Bright Horizons Family Solutions shares closed at $110.83 on Thursday. <a href="https://www.benzinga.com/quote/BFAM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rodman &amp; Renshaw raised Viracta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRX#NASDAQ">VIRX</a>) price target from $3.5 to $0.25. Rodman &amp; Renshaw downgraded the stock from Buy to Neutral. Viracta Therapeutics shares closed at $0.2370 on Thursday. <a href="https://www.benzinga.com/quote/VIRX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Raymond James raised the price target for Masimo Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASI#NASDAQ">MASI</a>) from $170 to $194. Raymond James analyst Jayson Bedford maintained an Outperform rating. Masimo shares closed at $171.02 on Thursday. <a href="https://www.benzinga.com/quote/MASI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Goldman Sachs slashed the price target for KinderCare Learning Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLC#NYSE">KLC</a>) from $41 to $35. Goldman Sachs analyst George Tong maintained a Buy rating. KinderCare Learning shares closed at $17.88 on Thursday. <a href="https://www.benzinga.com/quote/KLC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities boosted MakeMyTrip Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) price target from $119 to $130. B of A Securities analyst Sachin Salgaonkar maintained a Buy rating. MakeMyTrip shares settled at $116.21 on Thursday. <a href="https://www.benzinga.com/quote/MMYT/analyst-ratings">See how other analysts view this stock</a>. </li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42697989/dow-edges-higher-in-thin-holiday-trading-fear-declines-among-us-investors-but-fear-greed-index-remains-in-fear-zone">Dow Edges Higher In Thin Holiday Trading As Tesla, Apple Surge: Investor Sentiment Improves, But Greed Index Remains In &#8216;Fear&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

Analyst Ratings

BFAM

MASI

MMYT

VIRX

Masimo To Rally More Than 13%? Here Are 5 Top Analyst Forecasts For Friday

Safe and Green Development Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGD#NASDAQ">SGD</a>) ("SGD" or the "Company"), a real estate development company, is excited to share its expected timeline for completion of its joint venture developments in Southern Texas. The timeline below is only considering the existing portfolio of joint ventures; however, the Company will look to continue to expand its portfolio of joint ventures and initiate development on its existing joint venture properties in Oklahoma and Georgia.
2025
The Company expects to complete all 35 homes in the Sugar Developments throughout 2025. Additionally, the sitework for the 57 lots at Hacienda Olivia Phase II will be completed in the first quarter of 2025. The Company then expects to build the first 20 homes of that development throughout the rest of the year. The goal for homes delivered in 2025 will be approximately 55 homes. In Q1 2025, the Company will begin the sitework for Hacienda Olivia Phase IV for a total of approximately 113 lots with completion of the sitework expected in early 2026.
2026
The Company expects to complete the remaining 37 homes from the Hacienda Olivia Phase II development throughout 2026. SGD expects to deliver 35 homes from the Hacienda Olivia Phase IV development throughout the year. The goal for homes delivered in 2026 is approximately 72 homes. Like the previous year, the Company will begin sitework on Hacienda Olivia Phase III for 77 lots in Q1 of 2026.
2027
The Company expects to complete the remaining 78 homes from the Hacienda Olivia Phase IV development throughout 2027. The Company will also look to deliver 22 homes from the Hacienda Olivia Phase III development throughout the year. The goal for homes delivered in 2027 is approximately 100 homes.

General

Safe and Green Development Corporation Provides Expected Timeline For Joint Venture Development Portfolio

Vor Bio shares are trading higher after the company announced a $55.6 million private placement.

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2024/12/26/final-trades-starbucks-uber-berkshire-hathaway-and-twilio.html">Halftime Report Final Trades</a>,&#8221; Joshua Brown of Ritholtz Wealth Management named Starbucks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) as his<a href="https://www.benzinga.com/quote/SBUX/analyst-ratings"> final trade.</a>
On Dec. 11, Starbucks said its board of directors approved a quarterly cash dividend of 61 cents per share of outstanding Common Stock, which will be payable in cash on Feb. 28, 2025, to shareholders of record on Feb. 14, 2025.
Bryn Talkington of Requisite Capital Management said Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) announced a buyback and have really gotten started. The stock has got really strong support around $61.
Taiwan's Fair Trade Commission (FTC) has reportedly blocked Uber $950 million acquisition of Delivery Hero's Foodpanda business due to anti-competitive concerns. The merger, which was initially announced in May 2023, would have significantly increased Uber Eats' dominance in Taiwan's food delivery market, giving the combined company over 90% of the<a href="https://www.benzinga.com/markets/equities/24/12/42678877/ubers-foodpanda-acquisition-blocked-in-taiwan-due-to-competition-concerns"> market share, Reuters reported.</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Jim Lebenthal of Cerity Partners picked Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>), saying &#8220;go with the tried and true.&#8221;
On Nov. 4, UBS analyst Brian Meredith maintained Berkshire Hathaway with a Buy rating and lowered the price target from $538 to $531.
Joseph M. Terranova named Twilio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) as his final trade.
On Dec. 18, Morgan Stanley analyst Meta Marshall maintained Twilio with an Equal-Weight and raised the price target from $77 to $115, while Stifel analyst Parker Lane maintained the stock with a Hold and increased the price target from $80 to $110.
Price Action:
<ul>
<li>Starbucks shares gained by 2.2% to close at $91.86 on Tuesday.</li>
<li>Uber shares fell 0.2% to close at $61.56 during Tuesday's session.</li>
<li>Berkshire Hathaway rose 0.1% to settle at $459.08 on Tuesday.</li>
<li>Twilio shares gained 0.1% to close at $111.49 on Tuesday.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42684254/top-3-utilities-stocks-youll-regret-missing-in-december">Top 3 Utilities Stocks You&#8217;ll Regret Missing In December</a></li>
</ul>
Image: Shutterstock

Long Ideas

SBUX

TWLO

UBER

Starbucks, Uber, Twilio And A Financial Stock On CNBC's 'Final Trades'

CV Sciences Non-GAAP EPS of $0.00, revenue of $3.87M

CV Sciences ( ($CVSI) ) has issued an update. CV Sciences, Inc., a leader in consumer wellness products, reported a third-quarter 2024 revenue of $...

CV Sciences Reports Q3 Revenue and Product Launch

In this week's "Rising High," The Fly's recurring series focused on cannabis and psychedelic stock news, The Fly looks back on earnings, a Phase 3 ...

Rising High: Cannabis firms report quarterly earnings

CV Sciences, Inc. (CVSI) Q3 2024 Earnings Call Transcript

In this week's "Rising High," The Fly's recurring series focused on cannabis and psychedelic stock news, The Fly looks back on a clinic sale, effic...

Rising High: Numinus Wellness to sell five Utah clinics for $3.53M

CV Sciences enters into agreement to acquire Extract Labs

CV Sciences ( ($CVSI) ) has provided an announcement. CV Sciences, Inc. is set to acquire Extract Labs, a prominent cannabinoid product manufacture...

CV Sciences to Acquire Extract Labs for Growth

In this week's "Rising High," The Fly's recurring series focused on cannabis and psychedelic stock news, The Fly looks back on an acquisition, an e...

Rising High: Organigram acquires Motif Labs for C$90M upfront

In this edition of "Rising High," The Fly conducted an exclusive interview with Hans Eriksson, Chief Medical Officer of HMNC Brain Health, a global...

Rising High: Exclusive talk with biopharma company HMNC Brain Health

In this week's "Rising High," The Fly's recurring series focused on cannabis and psychedelic stock news, The Fly looks back on a default on rent ob...

Rising High: Innovative Industrial reports PharmaCann default

AAWH

ATAI

AYRWF

CANN

CBSTF

CMND

CMPS

CRLBF

CRON

CVSI

CYBN

ENVB

GNLN

GRWG

GTBIF

IIPR

IMCC

ITHUF

LOWLF

MEDIF

MNMD

NLCP

RHHBY

RHHVF

RLMD

SHFS

SPRB

TCNNF

TLRY

VREOF

VRNOF

Small Cap

Press Releases

CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results

CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024

CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER

Comments

CV Sciences

CV Sciences (CVSI) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル